期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
匹罗卡品全身应用可促进Sjgren综合征患者结膜上皮功能改善
1
作者 Aragona P. Di Pietro r. +2 位作者 spinella r. Mobrici M. 杨秀梅 《世界核心医学期刊文摘(眼科学分册)》 2006年第5期20-21,共2页
Aim: To evaluate the effect of oral pilocarpine treatment on conjunctival epithelium of patients with Sjgren’s syndrome (SS). Methods: 15 primary SS patients were included in this prospective, single masked, compar... Aim: To evaluate the effect of oral pilocarpine treatment on conjunctival epithelium of patients with Sjgren’s syndrome (SS). Methods: 15 primary SS patients were included in this prospective, single masked, comparative study. Patients underwent oral pilocarpine treatment for 2 months and were studied before (TO) and after 1 month (T1), 2 months (T2), and 15 days after treatment suspension (T3). Systemic and ocular symptoms, tear film break up time (BUT), corneal fluorescein vital staining, Schirmer I test, tear basal secretion test, and conjunctival imprinting were performed. Student’s t test and Mann-Whitney U test were used for statistics. Results: The conjunctival imprinting showed an increase of goblet cells number at T1 (1.6 (1.2) v 0.6 (0.7) at T0, p=0.025) improving at T2 (5.1 (1.7); p< 0.001 v T0 and T1). At T3 the number of goblet cells significantly decreased (1.9 (1.1); p< 0.001 v T2). An improvement of dry mouth started at T1 and returned towards baseline values at T3. For ocular symptoms, burning and foreign body sensation were improved at T1 while ocular dryness improved at T2. BUT showed a statistically significant improvement at T2. Conclusions: Oral pilocarpine induced an increase in goblet cells number and an amelioration of conjunctival epithelium not dependent on tear secretion. 展开更多
关键词 SJOGREN综合征 结膜上皮 匹罗卡品 全身应用 患者 单盲对照研究 泪膜破裂时间 分泌试验 原发性SS 治疗前
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部